EFFICACY AND SAFETY OF THE LOSARTAN/HYDROCHLOROTHIAZIDE COMBINATION (PREMINENT®) AFTER SWITCHING FROM AN ANGIOTENSIN II RECEPTOR BLOCKER: THE CLINICAL EVALUATION OF COMBINATION THERAPY FOR HYPERTENSIVE PATIENTS IN OMIYA (CONCERTO) STUDY: PP.14.381